Journey Medical (DERM) Non-Current Assets (2020 - 2026)

Journey Medical has reported Non-Current Assets for 7 years, with the latest figure at $26.6 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 14.23% year-over-year to $26.6 million; the trailing twelve-month figure through Mar 2026 stood at $113.0 million (up 13.39% YoY), and the FY2025 full-year result was $27.7 million, down 13.55% from the prior year.
• Non-Current Assets for Q1 2026 stood at $26.6 million, down from $27.7 million in the prior quarter.
• The five-year high for Non-Current Assets was $35.1 million in Q1 2023, with the low at $17.9 million in Q3 2024.
• Historically, Non-Current Assets has averaged $26.3 million across 5 years, with a median of $27.7 million in 2025.
• Annual changes were most pronounced in 2022 — Non-Current Assets soared 114.85% — and 2024, when it plunged 44.33%.
• Journey Medical's Non-Current Assets stood at $27.5 million in 2022, then decreased by 25.79% to $20.4 million in 2023, then jumped by 57.21% to $32.1 million in 2024, then retreated by 13.55% to $27.7 million in 2025, then dropped by 4.15% to $26.6 million in 2026.
• The last three Non-Current Assets figures came in at $26.6 million (Q1 2026), $27.7 million (Q4 2025), and $28.8 million (Q3 2025), per Business Quant data.